Position in EDIT
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$333,119
-$63,913 QoQ
Shares Held
134,866
-30.4% QoQ
Ownership
0.138%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in EDIT Over Time
Shares Held
Position Value (USD)
Derivatives in EDIT
reported options exposure · as of Sep 30, 2021CallValue
$3,142,620
CallShares
76,500
PutValue
$4,703,660
PutShares
114,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,548,750,242 across 347 Biotechnology names. EDIT ranks #270 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in EDIT
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $333,119 | 134,866 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $397,032 | 193,675 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $3,554,110 | 1,024,240 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $2,375,330 | 1,079,696 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,760,478 | 1,517,655 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $550,127 | 433,172 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,008,432 | 882,239 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,520,517 | 539,726 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $6,653,118 | 896,647 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,769,208 | 372,084 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,562,516 | 328,528 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,523,533 | 428,133 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $6,828,737 | 941,895 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $7,638,533 | 861,165 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $5,615,733 | 458,802 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,487,907 | 294,836 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $5,801,649 | 305,029 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $7,246,686 | 272,945 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $3,142,620 | 76,500 | Call | Defined | 2021-11-15 | |
| 2021-09-30 | $4,703,660 | 114,500 | Put | Defined | 2021-11-15 | |
| 2021-09-30 | $12,444,280 | 302,928 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $13,714,014 | 242,126 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $8,948,394 | 213,057 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $9,358,631 | 133,485 | Shares | Defined | 2021-02-10 | |
| 2020-12-31 | $3,519,522 | 50,200 | Put | Defined | 2021-02-10 | |
| 2020-12-31 | $1,198,881 | 17,100 | Call | Defined | 2021-02-10 | |
| 2020-09-30 | $952,636 | 33,950 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $3,476,329 | 117,523 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $811,818 | 40,939 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||